Morphosys AG's ticker is and the CUSIP is D55040105. A total of 1 filers reported holding Morphosys AG in Q3 2014. The put-call ratio across all filers is - and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $404,000 | -2.9% | 9,626 | -6.0% | 0.26% | -8.0% |
| Q2 2016 | $416,000 | -73.9% | 10,236 | -69.6% | 0.29% | -74.1% |
| Q1 2016 | $1,596,000 | -34.8% | 33,680 | -14.6% | 1.11% | -35.7% |
| Q4 2015 | $2,448,000 | -6.2% | 39,440 | -2.0% | 1.72% | +9.0% |
| Q3 2015 | $2,611,000 | -12.0% | 40,238 | -3.4% | 1.58% | +0.7% |
| Q2 2015 | $2,967,000 | +10.4% | 41,665 | -0.9% | 1.57% | +14.1% |
| Q1 2015 | $2,688,000 | -33.0% | 42,060 | -2.2% | 1.38% | -37.9% |
| Q4 2014 | $4,009,000 | +0.2% | 42,990 | +4.3% | 2.22% | -13.1% |
| Q3 2014 | $4,001,000 | -8.2% | 41,225 | -11.3% | 2.55% | -15.4% |
| Q2 2014 | $4,358,000 | +1.3% | 46,487 | +0.1% | 3.02% | -3.4% |
| Q1 2014 | $4,301,000 | +29.0% | 46,450 | +7.4% | 3.12% | +17.0% |
| Q4 2013 | $3,335,000 | -5.5% | 43,230 | -5.0% | 2.67% | -17.3% |
| Q3 2013 | $3,529,000 | +35.0% | 45,500 | -2.2% | 3.22% | +28.4% |
| Q2 2013 | $2,614,000 | – | 46,530 | – | 2.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Partner Investment Management, L.P. | 994 | $126,000 | 0.90% |
| PFM Health Sciences, LP | 122,275 | $15,504,000 | 0.74% |